Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabotegravir”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06273943
What this trial is testing

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Who this might be right for
Prevention
ANRS, Emerging Infectious Diseases 322
Large-scale testing (Phase 3)Active Not RecruitingNCT02938520
What this trial is testing

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Who this might be right for
HIV Infections
ViiV Healthcare 631
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07816250
What this trial is testing

A Phase 2b Study Evaluating VH4011499 Capsid Inhibitor Long-Acting Injectable Plus Cabotegravir in Treatment Naïve Adults (CINERGY)

Who this might be right for
HIV Infections
ViiV Healthcare 200
Early research (Phase 1)Study completedNCT02478463
What this trial is testing

Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 19
Early research (Phase 1)Study completedNCT01648257
What this trial is testing

Relative Bioavailability Study of GSK1265744 Formulations

Who this might be right for
Infections, Human Immunodeficiency Virus and Hepatitis
ViiV Healthcare 18
Post-approval studies (Phase 4)Study completedNCT06185452
What this trial is testing

Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine

Who this might be right for
HIV-1 Infection
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia 103
Early research (Phase 1)Study completedNCT02799264
What this trial is testing

Evaluate the Effect of High Fat Meal on Cabotegravir

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Not applicableLooking for participantsNCT07516548
What this trial is testing

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction+2 more
University of Alabama at Birmingham 105
Large-scale testing (Phase 3)Study completedNCT04399551
What this trial is testing

A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries

Who this might be right for
HIV Infections
ViiV Healthcare 437
Testing effectiveness (Phase 2)Study completedNCT02178800
What this trial is testing

Evaluating the Safety, Tolerability, and Pharmacokinetics of an Investigational, Injectable HIV Medicine (GSK1265744) in HIV-Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 199
Not applicableLooking for participantsNCT06807736
What this trial is testing

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

Who this might be right for
HIV InfectionSexual and Reproductive Health
Desmond Tutu HIV Foundation 1,800
Large-scale testing (Phase 3)Study completedNCT04001803
What this trial is testing

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

Who this might be right for
HIV Infections
ViiV Healthcare 115
Not applicableActive Not RecruitingNCT06451341
What this trial is testing

IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas

Who this might be right for
HIV
University of Nebraska 75
Early research (Phase 1)Study completedNCT00920296
What this trial is testing

DDI Study of Etravirine and GSK1265744

Who this might be right for
Healthy SubjectsInfection, Human Immunodeficiency Virus
GlaxoSmithKline 12
Testing effectiveness (Phase 2)Study completedNCT03739996
What this trial is testing

Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Looking for participantsNCT05660980
What this trial is testing

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

Who this might be right for
HIV-1-infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT02076178
What this trial is testing

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 127
Post-approval studies (Phase 4)Looking for participantsNCT07199335
What this trial is testing

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Who this might be right for
HIVSubstance Use Disorder (SUD)Injection Drug Use
Massachusetts General Hospital 100
Post-approval studies (Phase 4)Study completedNCT05549726
What this trial is testing

SEARCH CAB LA Dynamic Choice HIV Prevention Study Extension

Who this might be right for
HIV
University of California, San Francisco 984
Early research (Phase 1)Study completedNCT02354950
What this trial is testing

Evaluate Pharmacokinetic (PK) and Safety of GSK1265744 in Subjects With Hepatic Impairment and Control Healthy Volunteers

Who this might be right for
HIV Infections
ViiV Healthcare 16
Next Page